← Back to Search
Predicting BCG Response
Kyoto, Japan
N/A
Recruiting
Led By Hideki Furuya, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
To date, there are no diagnostics capable of predicting treatment response to intravesical BCG. Because of this severe limitation, nearly 50% of patients treated with BCG fail therapy and will a) require additional intravesical therapy or b) require cystectomy. A urine-based diagnostic that possesses the potential to accurately identify patients who will respond favorably to intravesical BCG is desperately needed.
See full description
Eligible Conditions
- Bladder Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Closest Location:Cedars-Sinai Medical Center· Los Angeles, CA· 1982 miles
Who is running the clinical trial?
University of California, Los AngelesOTHER
1,586 Previous Clinical Trials
10,422,226 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,057 Previous Clinical Trials
41,149,028 Total Patients Enrolled
Nonagen Bioscience CorporationIndustry Sponsor
4 Previous Clinical Trials
1,850 Total Patients Enrolled
University of California, San FranciscoOTHER
2,628 Previous Clinical Trials
19,028,492 Total Patients Enrolled
University of RochesterOTHER
882 Previous Clinical Trials
554,290 Total Patients Enrolled
Kyoto UniversityOTHER
37 Previous Clinical Trials
26,082 Total Patients Enrolled
Cedars-Sinai Medical CenterLead Sponsor
520 Previous Clinical Trials
164,220 Total Patients Enrolled
Hideki Furuya, PhDPrincipal InvestigatorCedars-Sinai Medical Center
2 Previous Clinical Trials
1,200 Total Patients Enrolled
Charles Rosser, MDStudy DirectorNonagen Bioscience Corporation
2 Previous Clinical Trials
1,350 Total Patients Enrolled
Amit Gupta, MDPrincipal InvestigatorCedars-Sinai Medical Center
3 Previous Clinical Trials
47,191 Total Patients Enrolled